LENZ Therapeutics Inc.

NASDAQ: LENZ · Real-Time Price · USD
38.97
-1.94 (-4.74%)
At close: Aug 15, 2025, 2:57 PM

LENZ Therapeutics Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a 15M n/a
Cost of Revenue
58K 2.41M 8.35M 734K
Gross Profit
-58K -2.41M 6.65M -734K
Operating Income
-58.61M -73.11M -105.64M -60.44M
Interest Income
8.55M 2.19M n/a n/a
Pretax Income
-49.77M -124.65M -101.05M -70.76M
Net Income
-49.77M -124.65M -101.05M -70.76M
Selling & General & Admin
28.75M 40.97M 32.85M 21.78M
Research & Development
29.8M 29.73M 64.44M 37.93M
Other Expenses
n/a n/a 19K n/a
Operating Expenses
58.55M 70.7M 97.29M 59.71M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
58.61M 73.11M 105.64M 60.44M
Income Tax Expense
1K -179K 347K 497.44K
Shares Outstanding (Basic)
21.28M 8.15M 7.84M 8.29M
Shares Outstanding (Diluted)
21.28M 8.15M 7.84M 8.29M
EPS (Basic)
-2.34 -15.3 -12.89 -8.54
EPS (Diluted)
-2.34 -15.3 -12.89 -8.54
EBITDA
-49.71M -122.24M -97.29M -70.03M
EBIT
-49.77M -124.65M -10.48M -70.76M
Depreciation & Amortization
58K 15K 8.35M 734K